Pegcetacoplan

ATC L04AJ03 · 7 markets · 13 records

Pegcetacoplan 7 markets · 13 records Forms

AU 5 records · 4 strengths

1,080 mg/20 mLinjectionEmpaveli also in US·GB·FR
1,080 mginjectionEMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial also in ES unknown
15 mginjectionSYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial unknown

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Empaveli ×2Syfovre ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 2 records · 2 strengths

1,080 mg/20 mLinjectionEmpaveli also in AU·GB·FR
15 mg/0.1 mLinjectionSyfovre

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ASPAVELI ×1Syfovre ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 1 records · 1 strengths

1,080 mg/20 mLinjectionAspaveli 1080mg/20ml solution for infusion vials also in AU·US·FR

CA 1 records · 1 strengths

54 mg/1 mLliquidEmpaveli

ES 1 records · 1 strengths

1,080 mginjectionASPAVELI also in AU

FR 1 records · 1 strengths

1,080 mg/20 mLinjectionASPAVELI 1080 mg, solution pour perfusion also in AU·US·GB

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	EU	FR
1,080 mg/20 mLRecorded as: 1.08 g/20 mL injection	Empaveli	Aspaveli 1080mg/20ml solution for infusion vials	not recorded	Empaveli	not recorded	not recorded	ASPAVELI 1080 mg, solution pour perfusion
1,080 mg injection	not recorded	not recorded	not recorded	EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial	ASPAVELI	not recorded	not recorded
54 mg/1 mL liquid	not recorded	not recorded	Empaveli	not recorded	not recorded	not recorded	not recorded
15 mg/0.1 mL injection	Syfovre	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
15 mg injection	not recorded	not recorded	not recorded	SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Empaveli Syfovre	not recorded	ASPAVELI Syfovre	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.